0001062993-21-006623.txt : 20210720 0001062993-21-006623.hdr.sgml : 20210720 20210720121225 ACCESSION NUMBER: 0001062993-21-006623 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210720 DATE AS OF CHANGE: 20210720 EFFECTIVENESS DATE: 20210720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Khiron Life Sciences Corp. CENTRAL INDEX KEY: 0001873100 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-406919 FILM NUMBER: 211100051 BUSINESS ADDRESS: STREET 1: 100 KING STREET WEST STREET 2: SUITE 1600 CITY: TORONTO STATE: A6 ZIP: M5X 1G5 BUSINESS PHONE: 647-556-5750 MAIL ADDRESS: STREET 1: 100 KING STREET WEST STREET 2: SUITE 1600 CITY: TORONTO STATE: A6 ZIP: M5X 1G5 D 1 primary_doc.xml X0708 D LIVE 0001873100 Khiron Life Sciences Corp. 100 KING STREET WEST SUITE 1600 TORONTO A6 ONTARIO, CANADA M5X 1G5 647-556-5750 BRITISH COLUMBIA, CANADA None None Corporation true ALVARO TORRES 100 King St.W., Suite 1600 Toronto A6 ONTARIO, CANADA M5X 1G5 Executive Officer Director JOEL FRIEDMAN 100 King St.W., Suite 1600 Toronto A6 ONTARIO, CANADA M5X 1G5 Executive Officer Director TEJINDER VIRK 100 King St.W., Suite 1600 Toronto A6 ONTARIO, CANADA M5X 1G5 Executive Officer Director Other Decline to Disclose 06b false 2021-07-06 true true true true true Units at a price of CDN $0.45 per unit. Each unit comprised of one common share and one common share purchase warrant (expiring November 26, 2025), and exercisable at a price of CDN$0.75 per warrant share false 0 ALLIANCE GLOBAL PARTNERS 8361 ATB CAPITAL MARKETS INC 155053 88 POST ROAD WEST 2ND FLOOR WESTPORT CT CONNECTICUT 06880 NY NEW YORK false 26366078 9887279 16478799 Units at a price of CDN $0.45 per unit. Each unit comprised of one common share and one common share purchase warrant (expiring November 26, 2025), and exercisable at a price of CDN$0.75 per warrant share false 4 692110 0 0 false Khiron Life Sciences Corp. /s/ Joel Friedman Joel Friedman CFO 2021-07-20